Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGASYS immunology sub-study in HBeAg-negative chronic hepatitis B
2005-000336-25Phase 3Completed
- Sponsor
- Roche
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of peginterferon alfa-2a in Chronic hepatitis B (CHB), sponsored by Roche. Primary endpoint: Exploratory immunological assessment. Started Jul 2005; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic hepatitis B (CHB)
Beyond the preview
Go deeper on 2005-000336-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000336-25.